Role of the HPV DNA Test in Follow-up of Treated Cervical Intraepithelial Neoplasia in Bangladesh |
Nessa, Ashrafun
(Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University)
Rashid, Mohammad Harun Ur (Planning and Research Unit, Directorate General of Health Services) Jahan, Munira (Department of Virology, Bangabandhu Sheikh Mujib Medical University) Ferdous, Noor-E (Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University) Nahar, Pervin Akhter Shamsun (Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University) Chowdhury, Afroza (Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University) |
1 | Ahmed T, Ashrafunnessa, Rahman J (2008). Development of a visual inspection programme for cervical cancer prevention in bangladesh. Elsevier Reproductive Health Matters, 16, 78-85. DOI ScienceOn |
2 | Akhter PS, Uddin MM, Sharma SK (1998). Patterns of malignant neoplasm: A three year study. Bangladesh Med J, 27, 29-32. |
3 | Coupe VM, Berkhof J, Verheijen RH, Meijer CJ (2007). Costeffectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG, 114, 416-24. DOI ScienceOn |
4 | Agorastos T, Sotiriadis A, Chatzigeorgiou K (2010). Can HPV testing replace the pap smear? Ann N Y Acad Sci, 14, 51-6. |
5 | Bollen LJM, Tjong-A-Hung S, van der Velden J, et al (1997). Clearance of human papillomavirus infection by treatment for cervical dysplasia. Sex Transm Dis, 24, 456-60. DOI ScienceOn |
6 | Bollen LJM, Tjong-A-Hung S, van der Velden J, et al (1996). Human papillomavirus dna after treatment of cervical dysplasia: low prevalence in normal cytologic smears. Cancer, 77, 2538-43. DOI ScienceOn |
7 | Cuzick J (2000). Human papillomavirus testing for primary cervical cancer screening. JAMA, 283, 108-9. DOI ScienceOn |
8 | Elfgren K, Jacobs, Walboomers J M M, Meijer C J L M, Dillner J (2002). Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol, 100, 965-71. DOI |
9 | Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008: cancer incidence and mortality worldwide. IARC Cancer Base, Volume 10, Lyon, France: IARC Press; http://globocan.iarc.fr. |
10 | International Agency for Research on Cancer (2004). IARC handbooks on cancer prevention. Volume 10, Cervix Cancer Screening. IARC Press: Lyon. |
11 | Jeong NH, Lee NW, Kim HJ, Kim T, Lee KW (2009). High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. J Obstet Gynaecol Res, 35, 706-11. DOI |
12 | Kjellberg L, Wadell G, Bergman F, et al (2000). Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. Am J Obstet Gynecol, 183, 1238-42. DOI ScienceOn |
13 | Kang WD, Oh MJ, Kim SM, et al (2010). Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure. Am J Obstet Gynecol, 203, 72. |
14 | Martin-Hirsch P, Lilford R, Jarvis G, Kitchener HC (1999). Efficacy of cervical-smear collection devices: a systematic review and meta-analysis. Lancet, 354, 1763-70. DOI |
15 | Kitchener H, Walker P, Nelson L, et al (2008). HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. BJOG, 15, 1001-7. |
16 | Manos MM, Kinney WK, Hurley LB, et al (1999). Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal papanicolaou results. JAMA, 281, 1605-10. |
17 | Mesher D, Szarewski A, Cadman L, et al (2010). Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HARTstudy. Br J Cancer, 27, 1405-10. |
18 | Nessa A, Hussain MA, Rahman JN, et al (2010). Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet, 111, 115-8. DOI ScienceOn |
19 | Nessa A, Hussain MA, Rashid MH, et al (2013a). Role of print and audiovisual media in cervical cancer prevention in Bangladesh. Asian Pac J Cancer Prev, 14, 7607-11. DOI |
20 | Nessa A, Nahar KN, Begum SA, et al (2013b). Comparison between visual inspection of cervix and cytology based screening procedures in Bangladesh. Asian Pac J Cancer Prev, 14, 3131-7. DOI ScienceOn |
21 | Philip EC, Andrew GG, et al (2012). Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J Clin Oncol, 30, 3044-50. DOI |
22 | Nobbenhuis MA, Meijer CJ, van den Brule AJ, et al (2001). Addition of high-risk HPV testing improves the current guidelines on follow up after treatment for cervical intraepithelial neoplasia. Br J Cancer, 84, 796-801. DOI ScienceOn |
23 | Soutter WP, de Barros Lopes A, Fletcher A, et al (1997). Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet, 349, 978-80. DOI ScienceOn |
24 | Paraskevaidis E, Arbyn M, Sotiriadis A, et al (2004). The role of HPV DNA testing in the follow up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev, 30, 205-11. DOI ScienceOn |
25 | Ribaldone R, Boldorini R, Capuano A, et al (2010). Role of HPV testing in the follow-up of women treated for cervical dysplasia. Arch Gynecol Obstet, 282, 193-7. DOI |
26 | Young TK, Jong ML, Soo-Young H, et al (2010). Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer, 126, 1903-9. |